Israel - English - Ministry of Health

cts chemical industries ltd, israel - selegiline hydrochloride - tablets - selegiline hydrochloride 5 mg - selegiline - selegiline - treatment of parkinson's disease or symptomatic parkinsonism.

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - terbinafine hydrochloride - solution - terbinafine hydrochloride 1 % - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum) , microsporum canis and epidermaphyton floccosum.yeast infections of the skin, principally those caused by the genus candida (e.g. candida albicans). pityriasis (tinea) versicolor due to pityrosporum orbiculare (also known as malassezia furfur).

Israel - English - Ministry of Health

vitamed pharmaceutical industries ltd - timolol as maleate - drops - timolol as maleate 5 mg/ml - timolol - timolol - for the reduction of elevated intraocular pressure.may be used in patients with chronic open angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension.

Israel - English - Ministry of Health

vitamed pharmaceutical industries ltd - timolol as maleate - drops - timolol as maleate 2.5 mg/ml - timolol - timolol - for the reduction of elevated intraocular pressure.may be used in patients with chronic open angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - polyethylene glycol 3350 - powder for solution - polyethylene glycol 3350 100 %w/w - osmotically acting laxatives - for the treatment of constipation.

Israel - English - Ministry of Health

megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.

Israel - English - Ministry of Health

megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.

Israel - English - Ministry of Health

astrazeneca (israel) ltd - saxagliptin as hydrochloride - film coated tablets - saxagliptin as hydrochloride 5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Israel - English - Ministry of Health

astrazeneca (israel) ltd - saxagliptin as hydrochloride - film coated tablets - saxagliptin as hydrochloride 2.5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Israel - English - Ministry of Health

cure medical & technical supply - chromium chloride; copper chloride; ferric chloride; manganese chloride; potassium iodide; sodium fluoride; sodium molybdate; sodium selenite; zinc chloride - concentrate for solution for infusion - copper chloride 0.34 mg/ml; potassium iodide 16.6 mcg/ml; sodium molybdate 4.85 mcg/ml; sodium selenite 6.9 mcg/ml; zinc chloride 1.36 mg/ml; chromium chloride 5.33 mcg/ml; ferric chloride 0.54 mg/ml; sodium fluoride 0.21 mg/ml; manganese chloride 99 mcg/ml - combinations of electrolytes - combinations of electrolytes - supplement in iv nutrition for adults to meet the requirements of trace elements.